Rajesh is a scientific key opinion leader with 25+ years in drug development, specializing in model-informed strategies for biologics, vaccines, and small molecules. Currently a Senior Distinguished Scientist at Certara, he leads strategic consulting and the CDDS centers of excellence.  Previously, he founded Merck’s quantitative clinical pharmacology department and held key roles at Aventis and Bristol-Myers Squibb. Rajesh holds a PhD in Pharmaceutical Sciences (University of British Columbia) and an MBA in Strategy and Innovation (Warwick).  Consistently recognized among the top 2% of influential scientists, his work includes 100+ publications, 89 posters, and 4 books.  He is an elected fellow of AAPS.

Check out Raj’s clinical pharmacology blogs.